FUNDAMENTALS · Fundamentals · JP Healthcare

Kanamic Network (3939) Fundamentals 2026 — P/E 18.2x, Revenue Analysis | SniperIQ

Kanamic Network (3939) is a JP-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ¥22.9B, trading at ¥483.00 on the JPX. This SniperIQ fundamentals page covers Kanamic Network's valuation (P/E 18.2x, P/B 4.6x), profitability (net margin 21.1%), revenue (¥5.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥22.9B
P/E (TTM)18.2x
Net Margin21.1%
Revenue (FY25)¥5.5B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Kanamic Network's market cap?

Kanamic Network (3939) has a market capitalization of approximately ¥22.9B, trading at ¥483.00 on the JPX. Market cap moves with the live share price.

What is Kanamic Network's P/E ratio?

Kanamic Network's trailing twelve-month P/E ratio is 18.2x, with a price-to-book (P/B) of 4.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Kanamic Network?

Kanamic Network runs a net profit margin of 21.1%, a gross margin of 64.0%, and an operating margin of 30.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Kanamic Network generate?

Kanamic Network reported revenue of ¥5.5B for fiscal year 2025, with net income of ¥1.1B and earnings per share (EPS) of 23.42. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Kanamic Network pay a dividend?

Kanamic Network offers a trailing dividend yield of about 1.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Kanamic Network financially healthy?

Kanamic Network carries a debt-to-equity ratio of 0.11x and a current ratio of 2.60x, with a market beta of 2.78. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Kanamic Network a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Kanamic Network (3939) the key facts are: market cap ¥22.9B, P/E 18.2x, revenue ¥5.5B, 52-week range 432-583. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Kanamic Network's full fundamentals live

Get Kanamic Network's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Labcorp Holdings (LH) fundamentals · Quest Diagnostics (DGX) fundamentals · Insmed (INSM) fundamentals · Oneness Biotech (4743) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons